We develop life changing medicines to free patients from the siege of autoimmune disease.
Navigating what’s next in synthetic biology, immunology and cell engineering to create a new class of T cell therapies programmed to modulate the underlying causes of autoimmunity.
Trailblazing Science Meets Unmet Patient Need
Kyverna is innovating cell therapy as a potentially curative approach to autoimmunity. Unlike current immunomodulatory treatments known to provide incremental disease control through chronic dosing, cell therapy holds the promise of modulating the immune system through a single infusion to achieve optimal and long-lasting disease control.
Smart Science, Smarter Medicines
Kyverna is developing living therapies to help restore balance to the immune system. Our therapeutic platform leverages advanced T cell engineering to target the underpinnings of autoimmunity, including chimeric antigen receptor T (CAR T) cells with properties uniquely suited for use in autoimmunity.